The human side of healing: How seeing loved ones helps COVID-19 patients
COVID-19 restrictions are keeping many patients isolated in the hospital, but a new study is highlighting what doctors, patients and families have seen: being near loved ones can play a role in healing specifically around a common brain dysfunction that comes with COVID-19.
Social Sharing
Lancet study on 2,088 patients showed family visitation linked to less delirium, a common risk of COVID-19
Posted: Feb 26, 2021 4:00 AM ET | Last Updated: March 1
Tom and Virginia Stevens of Nashville, Tenn., with Dr. Wes Ely. The couple was brought into the same hospital room for COVID-19 treatment after an initial separation during which Tom was found wandering the halls, disoriented and calling out for his wife of 66 years.(Submitted by Wes Ely)
The human side of healing: How seeing loved ones helps COVID-19 patients
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
COVID-19 variants: How can I protect myself from the new types of coronavirus?
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.
(2)
Wearable cardiac monitoring solution enables early detection and treatment of arrhythmia based on risk factors, according to results of the SCREEN-AF study published in JAMA Cardiology iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the results of a brand new SCREEN-AF study, led by researchers at Sunnybrook Health Sciences Centre in Toronto, Canada and University Hospital in Leipzig, Germany, which was published in
JAMA Cardiology
The transatlantic clinical trial found that Zio by iRhythm, an ambulatory cardiac monitoring solution, led to a tenfold increase in the detection of atrial fibrillation (AF) versus patients receiving standard clinical care. One out of every 20 patients in the heart monitoring group was found to have a new diagnosis of atrial fibrillation and, as a result, 75 percent of those patients were subsequently prescribed a blood thinner medication for
Anthony Henry and Willie Underwood III have a lot in common.
Both are Black men whose gene pool originated in West Africa, suggesting higher risks for aggressive prostate cancer. Both of their fathers were diagnosed with prostate cancer. Henry s father was diagnosed at age 64 and died at 68 from prostate cancer, and Underwood s dad was diagnosed with prostate cancer in his early 70s and is still alive at 81.
Both sons were diagnosed with prostate cancer at a young age: Underwood at 48 and Henry at 54.
Underwood in 2012 was diagnosed with a Gleason 3+4, known today as a favorable intermediate-risk prostate cancer. He qualified in some protocols for active surveillance (AS), monitoring the disease with prostate-specific antigen (PSA) tests, digital rectal exams, biopsies, and multi-parametric magnetic resonance imaging.